OUTCOMES IN FIRST RELAPSED-REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE-FIRST STUDY

被引：0
|
作者：
Visco, C.
Di Rocco, A.
Tisi, M.
Morello, L.
Evangelista, A.
Zilioli, V. R.
Rusconi, C.
Hohaus, S.
Sciarra, R.
Re, A.
Tecchio, C.
Chiappella, A.
Niebla, A. M.
McCulloch, R.
Gini, G.
Perrone, T.
Nassi, L.
Pennese, E.
Stefani, P. M.
Cox, M. C.
Bozzoli, V.
Fabbri, A.
Polli, V.
Ferrero, S.
De Celis, I. A.
Sica, A.
Arcaini, L.
Balzarotti, M.
Rule, S.
Vitolo, U.
机构：
[1] Univ Verona, Sect Hematol, Dept Med, Verona, Italy
[2] Sapienza Univ, Cellular Biotechnol & Hematol, Rome, Italy
[3] San Bortolo Hosp, Cell Therapy & Hematol, Vicenza, Italy
[4] Humanitas Clin & Res Ctr, Hematol, Milan, Italy
[5] Citta Salute & Sci, Clin Epidemiol, Turin, Italy
[6] CPO Piemonte, Turin, Italy
[7] ASST Grande Osped Metropolitano Niguarda, Hematol, Milan, Italy
[8] Univ Cattolica Sacro Cuore, Policlin Gemelli Fdn, Inst Hematol, Rome, Italy
[9] Fdn IRCCS Policlin San Matteo, Haematol Oncol, Pavia, Italy
[10] Spedali Civil Brescia, Hematol, Brescia, Italy
[11] Citta Salute & Sci Univ Hosp, Hematol, Turin, Italy
[12] Vall dHebron Inst Recerca, Hematol, Barcelona, Spain
[13] Univ Plymouth, Haematol, Plymouth, Devon, England
[14] Derriford Hosp, Plymouth, Devon, England
[15] Marche Polytech Univ, Dept Clin & Mol Sci, Hematol, Ancona, Italy
[16] Univ Bari, Hematol, Bari, Italy
[17] Azienda Osped Univ Maggiore Carita, Hematol, Novara, Italy
[18] PO Santo Spirito, UOSD Ctr Diag & Terapia Linfomi, Hematol, Florence, Italy
[19] Treviso Hosp, Hematol, Treviso, Italy
[20] AOU St Andrea, Hematol, Rome, Italy
[21] PO V Fazzi, Hematol, Lecce, Italy
[22] Azienda Osped Univ Senese, Hematol, Siena, Italy
[23] Univ Siena, Siena, Italy
[24] Osped Infermi, Hematol, Rimini, Italy
[25] Univ Torino, Mol Biotechnol & Hlth Sci, AOU Citta Salute & Sci Torino, Turin, Italy
[26] AUSLL IRCCS Santa Maria Nuova Hosp, Hematol, Reggio Emilia, Italy
[27] Policlin Napoli, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C001
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
    Trab, Trine
    Chanchiri, Iman
    Al-Mashhadi, Ahmed
    Berggreen, Emma
    Rasch, Stine
    Johansen, Mette
    Husby, Simon
    Clausen, Michael Roost
    Larsen, Thomas Stauffer
    Desseau-Arp, Andriette C.
    Christensen, Jacob Haaber
    Pedersen, Robert Schou
    Frederiksen, Mikael
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Gronbaek, Kirsten
    BLOOD, 2024, 144 : 6325 - 6326
  • [32] Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
    Yi, J. H.
    Kim, W. S.
    Kim, S. J.
    Yoon, D. H.
    Suh, C.
    Chang, M. H.
    Yang, D. H.
    Jo, J-C.
    Hyun, S. Y.
    Eom, H-S.
    Lee, J-O.
    Kwon, J. H.
    Han, S. H.
    Lee, S-S.
    Kwak, J-Y.
    Kim, S. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib
    Jain, Preetesh
    Kanagal-Shamanna, Rashmi
    Zhang, Shaojun
    OK, Chi Young
    Navsaria, Lucy
    Nastoupil, Loretta
    Lee, Hun Ju
    Tang, Guilin
    Yin, C. Cameron
    Badillo, Maria
    Nair, Ranjit
    Li, Shaoying
    Patel, Keyur M.
    Flowers, Christopher
    Vega, Francisco
    Wang, Linghua
    Wang, Michael L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E137 - E140
  • [34] Clinical Efficacy and Management of Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Coiffier, Bertrand
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 351 - 359
  • [35] SALVAGE TREATMENT WITH LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MANTLE CELL LYMPHOMA
    Zaja, F.
    De Luca, S.
    Vitolo, U.
    Orsucci, L.
    Levis, A.
    Salvi, F.
    Gargantini, L.
    Ravelli, E.
    Tucci, A.
    Bottelli, C.
    Balzarotti, M.
    Santoro, A.
    Brusamolino, E.
    Bonfichi, M.
    Di Rocco, A.
    Stelitano, C.
    Baldini, L.
    Pileri, S.
    Volpetti, S.
    Saccona, F.
    Ciccone, G.
    Ferranti, A.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 115 - 115
  • [36] Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study
    Morschhauser, Franck
    Bouabdallah, Kamal
    Stilgenbauer, Stephan
    Thieblemont, Catherine
    de Guibert, Sophie
    Zettl, Florian
    Gelbert, Lawrence M.
    Turner, P. Kellie
    Kambhampati, Siva Rama Prasad
    Li, Li
    Li, Lily Q.
    Buchanan, Sean
    Barriga, Susana
    Bear, Melissa M.
    Wilhelm, Martin
    Hess, Georg
    HAEMATOLOGICA, 2021, 106 (03) : 859 - 862
  • [37] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Fukuhara, Noriko
    Kitano, Toshiyuki
    Ishikawa, Takayuki
    Shibayama, Hirohiko
    Choi, Ilseung
    Hatake, Kiyohiko
    Uchida, Toshiki
    Nishikori, Momoko
    Kinoshita, Tomohiro
    Matsuno, Yoshihiro
    Nishikawa, Tomoaki
    Takahara, Satoko
    Tobinai, Kensei
    CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
  • [38] Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe
    Aydilek, Enver
    Wulf, Gerald
    Schwarz, Friedrich
    Bacher, Ulrike
    Rummel, Mathias
    Stiefel, Olga
    Kerkhoff, Andrea
    Maulhardt, Markus
    Melchardt, Thomas
    Pabst, Thomas
    Lenz, Georg
    Shumilov, Evgenii
    CANCER MEDICINE, 2024, 13 (10):
  • [39] Outcomes of Acalabrutinib Failures in Relapsed Mantle Cell Lymphoma
    Jain, Preetesh
    Zhang, Shaojun
    Kanagal-Shamanna, Rashmi
    Navsaria, Lucy
    Ok, Chi Young
    Tang, Guilin
    Yin, C. Cameron
    Badillo, Maria
    Chen, Wendy
    Oriabure, Onyeka
    Lee, Hun Ju
    Westin, Jason
    Nastoupil, Loretta J.
    Moghrabi, Omar
    Che, Yuxuan
    Samaniego, Felipe
    Ahmed, Sairah
    Nair, Ranjit
    Li, Shaoying
    Vega, Francisco
    Flowers, Christopher
    Wang, Linghua
    Wang, Michael
    BLOOD, 2020, 136
  • [40] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Kim, Sung-Won
    Izutsu, Koji
    Iwato, Kouji
    Fukuda, Takahiro
    Uchida, Naoyuki
    Amano, Itsuto
    Nakazawa, Hideyuki
    Kuroda, Junya
    Hashimoto, Hisako
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1445 - 1452
12345